Qiu Yunxiang,Zhang Qing,Xie Chunhong,et al.Safety and effectiveness of transcatheter pulmonary valve replacement in children: one case report[J].Journal of Clinical Pediatric Surgery,2025,(02):184-187.[doi:10.3760/cma.j.cn101785-202409003-014]
Click Copy

Safety and effectiveness of transcatheter pulmonary valve replacement in children: one case report

References:

[1] 李建强,苏俊武.经皮介入肺动脉瓣置入术的研究进展[J].中华胸心血管外科杂志,2016,32(10):634-637.DOI:10.3760/cma.j.issn.1001-4497.2016.08.015. Li JQ,Su JW.Advances in percutaneous pulmonary valve implantation[J].Chin J Thorac Cardiovasc Surg,2016,32(10):634-637.DOI:10.3760/cma.j.issn.1001-4497.2016.08.015.
[2] Bonhoeffer P,Boudjemline Y,Saliba Z,et al.Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction[J].Lancet,2000,356(9239):1403-1405.DOI:10.1016/S0140-6736(00)02844-0.
[3] Bokma JP,Geva T,Sleeper LA,et al.Improved outcomes after pulmonary valve replacement in repaired tetralogy of Fallot[J].J Am Coll Cardiol,2023,81(21):2075-2085.DOI:10.1016/j.jacc.2023.02.052.
[4] Van den Eynde J,Sá MPBO,Vervoort D,et al.Pulmonary valve replacement in tetralogy of Fallot: an updated meta-analysis[J].Ann Thorac Surg,2022,113(3): 1036-1046.DOI:10.1016/j.athoracsur.2020.11.040.
[5] Park WY,Kim GB,Lee SY,et al.Long-term outcome and risk factor analysis of surgical pulmonary valve replacement in congenital heart disease[J].Congenit Heart Dis,2022,17(3):335-350.DOI:10.32604/chd.2022.018666.
[6] Megaly M,Han K,Sedhom R,et al.Outcomes of percutaneous and surgical pulmonary valve implantation[J].Cardiovasc Revasc Med,2021,32:27-32.DOI: 10.1016/j.carrev.2020.12.035.
[7] 中国医师协会心血管内科医师分会结构性心脏病学组,亚洲心脏病学会,国家放射与治疗临床医学研究中心.经导管肺动脉瓣置换术亚洲专家共识[J].中国介入心脏病学杂志,2023,31(6):404-412.DOI:10.3969/j.issn.1004-8812.2023.06.002. Group of Structural Cardiology,Branch of Cardiovascular Physicians,Chinese Medical Doctor Association; Asian Society of Cardiology,National Clinical Research Center for Interventional Medicine: Asian Expert Consensus on Transcatheter Pulmonary Valve Replacement[J].Chin J Intervent Cardiol,2023,31(6):404-412.DOI:10.3969/j.issn.1004-8812.2023.06.002.
[8] Pagourelias ED,Daraban AM,Mada RO,et al.Right ventricular remodelling after transcatheter pulmonary valve implantation[J].Catheter Cardiovasc Interv,2017,90(3):407-417.DOI:10.1002/ccd.26966.
[9] Borik S,Crean A,Horlick E,et al.Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes?[J].Circ Cardiovasc Interv,2015,8(2):e001745.DOI:10.1161/CIRCINTERVENTIONS.114.001745.
[10] Martin MH,Shahanavaz S,Peng LF,et al.Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg[J].Catheter Cardiovasc Interv,2018,91(3):485-494.DOI:10.1002/ccd.27432.
[11] Jin QC,Long YL,Zhang GJ,et al.Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract[J].Catheter Cardiovasc Interv,2024,103(2):359-366.DOI:10.1002/ccd.30916.
[12] El-Saiedi SA,Attia WA,Hanna BM,et al.Staged percutaneous management of pulmonary atresia and intact interventricular septum: stretching the limits[J].J Interv Cardiol,2023,2023:9709227.DOI:10.1155/2023/9709227.

Memo

收稿日期:2024-9-2。
基金项目:国家自然科学基金面上项目(82270309);中央引导地方科技发展资金项目(2023ZY1058);浙江省自然科学基金(LQ22H260004);浙江大学医学院附属儿童医院青年临床科学家培育专项基金(CHZJU2022ys004)
通讯作者:徐玮泽,Email:weizexu@zju.edu.cn

Last Update: 2025-02-28